Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Appointed director
|
|
Sonoma Pharmaceuticals, Inc. (SNOA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/21/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| MCLAUGHLIN JOHN (Director) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.08, valued at
$21.6k
|
|
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2022 |
3
| White Chad Norman (Interim CFO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc. |
| 01/14/2022 |
4
| Weigerstorfer Philippe (Director) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.6, valued at
$138k
|
|
| 01/14/2022 |
4
| Trombly Amy Moss (CEO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.6, valued at
$138k
|
|
| 01/14/2022 |
4
| Thornton Bruce (COO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.6, valued at
$138k
|
|
| 01/14/2022 |
4
| MCLAUGHLIN JOHN (Director) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.6, valued at
$138k
|
|
| 01/14/2022 |
4
| DVONCH JEROME J (CFO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.6, valued at
$138k
|
|
| 01/14/2022 |
4
| Birnbaum Jay E (Director) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.6, valued at
$138k
|
|
| 01/13/2021 |
4
| Thornton Bruce (COO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 27,777 options to buy
@ $8.03, valued at
$223k
|
|
| 01/08/2021 |
4
| DVONCH JEROME J (CFO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 27,777 options to buy
@ $8.03, valued at
$223k
|
|
| 01/08/2021 |
4
| Trombly Amy Moss (CEO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 27,777 options to buy
@ $8.03, valued at
$223k
|
|
| 09/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/24/2020 |
4
| Edwards Robert Grant (CFO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 2,609 shares
@ $0 |
|
| 04/24/2020 |
4
| Dal Poggetto John (CFO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 3,086 shares
@ $0 |
|
| 04/23/2020 |
3
| Edwards Robert Grant (CFO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc. |
| 01/03/2020 |
4
| Trombly Amy Moss (CEO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 13,491 options to buy
@ $4.36, valued at
$58.8k
Granted 2,380 options to buy
@ $4.55, valued at
$10.8k
|
|
| 01/03/2020 |
4
| Dal Poggetto John (CFO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 13,000 options to buy
@ $4.36, valued at
$56.7k
|
|
| 10/17/2019 |
3
| Trombly Amy Moss (Interim CEO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc. |
| 10/15/2019 |
3
| Dal Poggetto John (CFO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc. |
| 01/15/2019 |
4
| Schutz James J (Former CEO and Former Director) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 5,271 options to buy
@ $38.15, valued at
$201.1k
Unknown transaction of 3,571 options to buy
@ $66.85, valued at
$238.7k
Unknown transaction of 1,785 options to buy
@ $68.95, valued at
$123.1k
Unknown transaction of 3,928 options to buy
@ $70.35, valued at
$276.3k
Unknown transaction of 1,428 options to buy
@ $56, valued at
$80k
Unknown transaction of 5,357 options to buy
@ $43.75, valued at
$234.4k
Unknown transaction of 4,285 options to buy
@ $32.55, valued at
$139.5k
Unknown transaction of 20,000 options to buy
@ $30, valued at
$600k
Unknown transaction of 50,000 options to buy
@ $4.81, valued at
$240.5k
Unknown transaction of 30,000 options to buy
@ $7.06, valued at
$211.8k
Unknown transaction of 67,733 options to buy
@ $2.41, valued at
$163.2k
|
|
| 01/15/2019 |
4
| Miller Robert E (Former CFO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 5,271 options to buy
@ $38.15, valued at
$201.1k
Unknown transaction of 5,357 options to buy
@ $68.95, valued at
$369.4k
Unknown transaction of 357 options to buy
@ $70.35, valued at
$25.1k
Unknown transaction of 5,000 options to buy
@ $56, valued at
$280k
Unknown transaction of 1,785 options to buy
@ $43.75, valued at
$78.1k
Unknown transaction of 4,285 options to buy
@ $32.55, valued at
$139.5k
Unknown transaction of 5,351 options to buy
@ $14.85, valued at
$79.5k
Unknown transaction of 26,020 options to buy
@ $19.5, valued at
$507.4k
Unknown transaction of 7,912 options to buy
@ $5.8, valued at
$45.9k
Unknown transaction of 50,000 options to buy
@ $4.81, valued at
$240.5k
Unknown transaction of 30,000 options to buy
@ $7.06, valued at
$211.8k
|
|
| 01/11/2019 |
4
| Sandford Frederick J (CEO and Interim CFO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.717, valued at
$286.8k
Granted 50,000 options to buy
@ $0.717, valued at
$35.9k
|
|
| 12/21/2018 |
3
| Sandford Frederick J (CEO and Interim CFO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc. |
| 09/21/2018 |
3
| Weigerstorfer Philippe (Director) has filed a Form 3 on Sonoma Pharmaceuticals, Inc. |
| 07/24/2018 |
4
| Schutz James J (CEO) has filed a Form 4 on Sonoma Pharmaceuticals, Inc.|
Txns:
| Granted 67,733 options to buy
@ $2.41, valued at
$163.2k
|
|
|
|
|